Kadima Neuropsychiatry Institute specializes in providing advanced treatments for mental illness. We are also conducting research to develop innovative treatments.
We are seeking participants for a clinical study investigating an experimental psychedelic compound for the treatment of Adjustment Disorder in Cancer and Parkinson's patients.
The sponsor of this study is Reunion Neuroscience, and the Principal Investigator is David Feifel, MD, PhD. The research is being conducted at Kadima Neuropsychiatry Institute, located in La Jolla, California.
Participants will be compensated for their time and travel expenses.
If you are interested in being considered for this study, please complete the following brief survey to determine your initial eligibility. It should take about 3 minutes to complete.
This survey platform is HIPAA-compliant and designed to protect your protected health information (PHI). Information entered will only be used for the purposes of eligibility assessment by KADIMA Research Staff members.